Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,000
Closed -$1K 2816
2023
Q4
$1K Buy
+5,000
New +$348K ﹤0.01% 3334
2022
Q4
Sell
-4,600
Closed -$25K 4719
2022
Q3
$25K Buy
4,600
+4,000
+667% +$277K ﹤0.01% 2436
2022
Q2
$4K Buy
600
+200
+50% +$14.8K ﹤0.01% 3863
2022
Q1
$1K Sell
400
-1,000
-71% -$71.9K ﹤0.01% 4977
2021
Q4
$2K Sell
1,400
-4,200
-75% -$309K ﹤0.01% 4739
2021
Q3
$12K Buy
5,600
+2,300
+70% +$172K ﹤0.01% 3767
2021
Q2
$19K Buy
3,300
+1,900
+136% +$127K ﹤0.01% 3341
2021
Q1
$7K Buy
+1,400
New +$106K ﹤0.01% 4105
2018
Q2
Sell
-2,100
Closed -$3K 4460
2018
Q1
$3K Buy
+2,100
New +$84.9K ﹤0.01% 3564
2017
Q4
Sell
-25,100
Closed -$60K 5288
2017
Q3
$60K Buy
25,100
+15,400
+159% +$622K ﹤0.01% 2077
2017
Q2
$10K Sell
9,700
-10,000
-51% -$441K ﹤0.01% 4152
2017
Q1
$31K Buy
19,700
+8,800
+81% +$359K ﹤0.01% 2866
2016
Q4
$5K Buy
10,900
+4,900
+82% +$189K ﹤0.01% 4903
2016
Q3
$3K Buy
6,000
+4,200
+233% +$159K ﹤0.01% 5363
2016
Q2
$1K Buy
+1,800
New +$62.3K ﹤0.01% 6080

Other funds holding HOLX

Cutler Group's HOLX Position: Q1 2023 in Review

Cutler Group sold out of Hologic (HOLX) in Q1 2023, closing a stake of 675 shares — an estimated $50K sold.

Cutler Group first reported a position in HOLX in Q4 2015 and held it in 20 quarters. The position peaked at $922K in Q4 2015. 707 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Cutler Group reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 675 Hologic shares in Q1 2023, an estimated $50K.
  • Cutler Group first reported a position in Hologic in Q4 2015 and held it in 20 quarters.
  • Cutler Group's Hologic position peaked at $922K in Q4 2015.
  • 707 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.